Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 13639

Tarzana, CA 91356

Study Summary:

This is a randomized, double-blind parallel group study. It will compare the safety and efficacy, and initial combination therapy with linagliptin (5mg) + pioglitazone (15mg, 30mg or 45mg) versus monotherapy with pioglitizone (15mg, 30mg or 45mg), or linagliptin 5mg once daily for 30 weeks, followed by a 54-week blinded trial period with linigliptin (5mg) + pioglitizone (30mg or 45mg) in patients with Type 2 Diabetes who have insufficient glycemic control and are on diet and exercise only.

Qualified Participants Must:

• Have a diagnosis of Type 2 Diabetes
• Be 18-80 years of age
• Have an HbA1c of 7-10.5% on diet and exercise alone without oral antidiabetic therapy within 10 weeks of starting the trial

Qualified Participants May Receive:

Study medication, labwork, glucometer with strips/supplies at no cost and compensation for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.